Gema Miñana

Dr. Gema Miñana

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The American Journal of Cardiology
Verified
Journal Article
Closed access
ESEnrique Santas
Enrique Santas
PPPatricia Palau
Patricia Palau
MGMarco Guazzi
Marco Guazzi
RERafael de la Espriella
Rafael de la Espriella
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez

1 June 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
MSMeritxell Soler
Meritxell Soler
GMGema Miñana
Gema Miñana
ESEnrique Santas
Enrique Santas
ENEduardo Núñez
Eduardo Núñez
RERafael de la Espriella
Rafael de la Espriella
JNJulio Núñez
Julio Núñez

1 June 2021 in Medicina Clinica
Verified
Journal Article
Closed access
LILLacer Iborra
LLacer Iborra
MGMari Ángeles Gallardo
Mari Ángeles Gallardo
PPPatricia Palau
Patricia Palau
MMMari Carmen Moreno
Mari Carmen Moreno
CCCarla Castillo-Laborde
Carla Castillo-Laborde
JNJulio Núñez
Julio Núñez

1 January 2022 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
RERafael de la Espriella
Rafael de la Espriella
ABAntoni Bayés-Genís
Antoni Bayés-Genís
PLPau Llàcer
Pau Llàcer
PPPatricia Palau
Patricia Palau
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez

8 April 2021 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Open access
PDF file
GNGonzalo Núñez-Marín
Gonzalo Núñez-Marín
RERafael de la Espriella
Rafael de la Espriella
ESEnrique Santas
Enrique Santas
MLMiguel Lorenzo
Miguel Lorenzo
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez
Intrarenal venous flow (IRVF) measured by Doppler ultrasound has gained interest as a potential surrogate marker of renal congestion and adverse outcomes in heart failure. In this work, we aimed to determine if antigen carbohydrate 125 (CA125) and plasma amino-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with congestive IRVF patterns (i.e., biphasic and monophasic) in acute heart failure (AHF). We prospectively enrolled a consecutive cohort of 70 patients hospitalized for AHF. Renal Doppler ultrasound was assessed within the first 24-h of hospital admission. The mean age of the sample was 73.5 ± 12.3 years; 47.1% were female, and 42.9% exhibited heart failure with preserved ejection fraction. The median (interquartile range) for NT-proBNP and CA125 were 6149 (3604–12 330) pg/mL and 64 (37–122) U/mL, respectively. The diagnostic performance of both exposures for identifying congestive IRVF patterns was tested using the receiving operating curve (ROC). The cut-off for CA125 of 63.5 U/mL showed a sensibility and specificity of 67% and 74% and an area under the ROC curve of 0.71. After multivariate adjustment, CA125 remained non-linearly and positively associated with congestive IRVF (P-value = 0.008) and emerged as the most important covariate explaining the variability of the model (R2: 47.5%). Under the same multivariate setting, NT-proBNP did not show to be associated with congestive IRVF patterns (P-value = 0.847). CA125 and not NT-proBNP is a useful marker for identifying patients with AHF and congestive IRVF patterns.

17 April 2018 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
JNJulio Núñez
Julio Núñez
PPPatricia Palau
Patricia Palau
EDEloy Domínguez
Eloy Domínguez
AMAnna Mollar
Anna Mollar
ENEduardo Núñez
Eduardo Núñez
ABAntoni Bayes
Antoni Bayes